Ciccone M, Trousdell M, Dos Santos C
J Mammary Gland Biol Neoplasia. 2020; 25(4):351-366.
PMID: 33131024
PMC: 7960614.
DOI: 10.1007/s10911-020-09465-0.
Rossetti S, Bshara W, Reiners J, Corlazzoli F, Miller A, Sacchi N
Cancer Lett. 2016; 380(2):375-383.
PMID: 27422542
PMC: 5003754.
DOI: 10.1016/j.canlet.2016.07.003.
Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker T
BMC Cancer. 2015; 15:647.
PMID: 26424146
PMC: 4590702.
DOI: 10.1186/s12885-015-1652-8.
Godde N, Sheridan J, Smith L, Pearson H, Britt K, Galea R
PLoS Genet. 2014; 10(5):e1004323.
PMID: 24852022
PMC: 4031063.
DOI: 10.1371/journal.pgen.1004323.
Rejniak K
Scientifica (Cairo). 2013; 2012:132978.
PMID: 24278670
PMC: 3820568.
DOI: 10.6064/2012/132978.
The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration.
Wu X, Gallo K
PLoS One. 2013; 8(8):e71258.
PMID: 23967175
PMC: 3743866.
DOI: 10.1371/journal.pone.0071258.
Epithelial cell differentiation regulated by MicroRNA-200a in mammary glands.
Nagaoka K, Zhang H, Watanabe G, Taya K
PLoS One. 2013; 8(6):e65127.
PMID: 23750238
PMC: 3672172.
DOI: 10.1371/journal.pone.0065127.
The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan K, Schwab L, Karakashev S, Franchetti L, Johannes G, Seagroves T
J Biol Chem. 2013; 288(22):15865-77.
PMID: 23585570
PMC: 3668743.
DOI: 10.1074/jbc.M112.426999.
p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.
Camacho Leal M, Pincini A, Tornillo G, Fiorito E, Bisaro B, Di Luca E
PLoS One. 2012; 7(12):e49817.
PMID: 23239970
PMC: 3519769.
DOI: 10.1371/journal.pone.0049817.
CPEB-mediated ZO-1 mRNA localization is required for epithelial tight-junction assembly and cell polarity.
Nagaoka K, Udagawa T, Richter J
Nat Commun. 2012; 3:675.
PMID: 22334078
PMC: 4334452.
DOI: 10.1038/ncomms1678.
A novel MCF-10A line allowing conditional oncogene expression in 3D culture.
Herr R, Wohrle F, Danke C, Berens C, Brummer T
Cell Commun Signal. 2011; 9:17.
PMID: 21752278
PMC: 3163222.
DOI: 10.1186/1478-811X-9-17.
Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling.
Tang J, Enderling H, Becker-Weimann S, Pham C, Polyzos A, Chen C
Integr Biol (Camb). 2011; 3(4):408-21.
PMID: 21373705
PMC: 4009383.
DOI: 10.1039/c0ib00092b.
Linking changes in epithelial morphogenesis to cancer mutations using computational modeling.
Rejniak K, Wang S, Bryce N, Chang H, Parvin B, Jourquin J
PLoS Comput Biol. 2010; 6(8).
PMID: 20865159
PMC: 2928778.
DOI: 10.1371/journal.pcbi.1000900.
Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
Whelan K, Caldwell S, Shahriari K, Jackson S, Franchetti L, Johannes G
Mol Biol Cell. 2010; 21(22):3829-37.
PMID: 20861305
PMC: 2982135.
DOI: 10.1091/mbc.E10-04-0353.
Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.
Godde N, Galea R, Elsum I, Humbert P
J Mammary Gland Biol Neoplasia. 2010; 15(2):149-68.
PMID: 20461450
DOI: 10.1007/s10911-010-9180-2.
ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen K, Caldwell S, Shahriari K, Jackson S, Whelan K, Klein-Szanto A
J Cell Sci. 2010; 123(Pt 8):1373-82.
PMID: 20332114
PMC: 3705932.
DOI: 10.1242/jcs.050906.
ErbB3 is required for ductal morphogenesis in the mouse mammary gland.
Jackson-Fisher A, Bellinger G, Breindel J, Tavassoli F, Booth C, Duong J
Breast Cancer Res. 2008; 10(6):R96.
PMID: 19019207
PMC: 2656891.
DOI: 10.1186/bcr2198.